Eden Research plc (LON:EDEN – Get Free Report)’s share price was up 2.8% on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares changed hands during mid-day trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey acquired 540,540 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The company has a market capitalization of £19.73 million, a PE ratio of -200.00 and a beta of 0.92. The firm has a 50-day moving average of GBX 3.88 and a two-hundred day moving average of GBX 4.01. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25.
About Eden Research
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Featured Stories
- Five stocks we like better than Eden Research
- What is the Dow Jones Industrial Average (DJIA)?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- 3 Dividend Kings To Consider
- What Does the Future Hold for Eli Lilly?
- Transportation Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.